Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia - PubMed (original) (raw)
Comparative Study
. 2002 Apr 15;99(8):2985-91.
doi: 10.1182/blood.v99.8.2985.
Affiliations
- PMID: 11929790
- DOI: 10.1182/blood.v99.8.2985
Free article
Comparative Study
Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia
Michelle M Le Beau et al. Blood. 2002.
Free article
Abstract
Acute promyelocytic leukemia (APL) is characterized by the t(15;17)(q22;q11.2), which results in the PML-RARA fusion gene. In previous studies, we demonstrated that expression of a human PML-RARA complementary DNA in murine granulocyte precursor cells initiated the development of leukemia. However, leukemogenesis by PML-RARA required additional genetic alterations. To identify genetic changes that cooperate with PML-RARA in leukemogenesis, we performed spectral karyotyping analysis of myeloid leukemias from hMRP8-PML-RARA mice (11 cases) and from mice coexpressing PML-RARA and BCL2 (8 cases). Clonal abnormalities were detected in 18 of 19 cases (95%). Recurring numerical abnormalities identified in these murine leukemias included +15 (15 cases, 79%); loss of a sex chromosome (12 cases, 63%); +8 (10 cases, 53%); +10 (9 cases, 47%); +4, +7, or +14 (8 cases each, 42%); +16 (7 cases, 37%); and +6 (5 cases, 26%). In a series of 965 patients with APL, we identified secondary abnormalities in 368 (38%). The most common recurring abnormalities were +8 or partial trisomy of 8q (120 patients, 12.4%) and ider(17) t(15;17) (42 patients, 4.4%). The critical consequence of +8 in human leukemias appears to be the gain of 8q24, which is syntenic to mouse 15. Thus, our results suggest that PML-RARA-initiated murine leukemia is associated with a defined spectrum of genetic changes, and that these secondary mutations recapitulate, in part, the cytogenetic abnormalities found in human APL.
Similar articles
- Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.
Le Beau MM, Davis EM, Patel B, Phan VT, Sohal J, Kogan SC. Le Beau MM, et al. Blood. 2003 Aug 1;102(3):1072-4. doi: 10.1182/blood-2003-01-0155. Epub 2003 Apr 10. Blood. 2003. PMID: 12689927 - In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes.
Mozziconacci MJ, Liberatore C, Brunel V, Grignani F, Arnoulet C, Ferrucci PF, Fernandez F, Sainty D, Pelicci PG, Birg F, Lafage-Pochitaloff M. Mozziconacci MJ, et al. Genes Chromosomes Cancer. 1998 Jul;22(3):241-50. doi: 10.1002/(sici)1098-2264(199807)22:3<241::aid-gcc10>3.0.co;2-r. Genes Chromosomes Cancer. 1998. PMID: 9624536 - A PML/RARA chimeric gene on chromosome 2 in a patient with acute promyelocytic leukemia (M3) associated with a new variant translocation: t(2;15;17)(q21;q22;q21).
Fujishima M, Takahashi N, Miura I, Kobayashi Y, Kume M, Nishinari T, Miura AB. Fujishima M, et al. Cancer Genet Cytogenet. 2000 Jul 1;120(1):80-2. doi: 10.1016/s0165-4608(99)00238-1. Cancer Genet Cytogenet. 2000. PMID: 10913680 - Isochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia resulting in an additional copy of the RARA-PML fusion gene: report of 4 cases and review of the literature.
Manola KN, Karakosta M, Sambani C, Terzoudi G, Pagoni M, Gatsa E, Papaioannou M. Manola KN, et al. Acta Haematol. 2010;123(3):162-70. doi: 10.1159/000294959. Epub 2010 Mar 11. Acta Haematol. 2010. PMID: 20224268 Review. - Molecular analysis of the t(15;17) translocation in acute promyelocytic leukaemia.
Borrow J, Solomon E. Borrow J, et al. Baillieres Clin Haematol. 1992 Oct;5(4):833-56. doi: 10.1016/s0950-3536(11)80048-x. Baillieres Clin Haematol. 1992. PMID: 1339190 Review.
Cited by
- A case of acute promyelocytic leukemia variant with derivative chromosome 3 der(3)t(3;8) associated with 8q partial gain.
Nozza F, Vona G, Trino S, D'Auria F, La Rocca F, Grieco V, Possidente L, De Luca L, Musto P. Nozza F, et al. Mol Cytogenet. 2019 Jul 5;12:32. doi: 10.1186/s13039-019-0445-1. eCollection 2019. Mol Cytogenet. 2019. PMID: 31312256 Free PMC article. - Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia.
Gaillard C, Surianarayanan S, Bentley T, Warr MR, Fitch B, Geng H, Passegué E, de Thé H, Kogan SC. Gaillard C, et al. Blood Adv. 2018 Oct 9;2(19):2462-2466. doi: 10.1182/bloodadvances.2018018929. Blood Adv. 2018. PMID: 30266821 Free PMC article. - Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice.
Voisset E, Moravcsik E, Stratford EW, Jaye A, Palgrave CJ, Hills RK, Salomoni P, Kogan SC, Solomon E, Grimwade D. Voisset E, et al. Blood. 2018 Feb 8;131(6):636-648. doi: 10.1182/blood-2017-07-794784. Epub 2017 Nov 30. Blood. 2018. PMID: 29191918 Free PMC article. - KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.
Burgess MR, Hwang E, Mroue R, Bielski CM, Wandler AM, Huang BJ, Firestone AJ, Young A, Lacap JA, Crocker L, Asthana S, Davis EM, Xu J, Akagi K, Le Beau MM, Li Q, Haley B, Stokoe D, Sampath D, Taylor BS, Evangelista M, Shannon K. Burgess MR, et al. Cell. 2017 Feb 23;168(5):817-829.e15. doi: 10.1016/j.cell.2017.01.020. Epub 2017 Feb 16. Cell. 2017. PMID: 28215705 Free PMC article. - DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.
Meyer SE, Qin T, Muench DE, Masuda K, Venkatasubramanian M, Orr E, Suarez L, Gore SD, Delwel R, Paietta E, Tallman MS, Fernandez H, Melnick A, Le Beau MM, Kogan S, Salomonis N, Figueroa ME, Grimes HL. Meyer SE, et al. Cancer Discov. 2016 May;6(5):501-15. doi: 10.1158/2159-8290.CD-16-0008. Epub 2016 Mar 25. Cancer Discov. 2016. PMID: 27016502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases